MY-10

N/A

Report date: 2026/04/21 20:00:18
NME

Base Information

Drug NameMY-10
Drug Alias NameMY-10
ClassificationSmall molecules
Mechanisms of ActionReceptor-type tyrosine-protein phosphatase zeta inhibitors
TargetsReceptor-type tyrosine-protein phosphatase zeta
Therapy Area/IndicationsAlcoholismCarcinoma, Squamous Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSpainMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesCeu San Pablo UniversityUniversity Of Illinois At Chicago
China Registration ClassN/A

Develop Information

Active CompaniesCeu San Pablo UniversityUniversity Of Illinois At ChicagoWest China Hospital Of Sichuan University
Inactive CompaniesN/A
Active IndicationsAlcoholismCarcinoma, Squamous Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A